Right Scan Right Time Hosts Successful Patient Fly-In Advocating for Increased Access to AI Cancer Screenings

In July, five patient leaders traveled to Capitol Hill to share their personal stories and speak to their lawmakers about the need to expand access to artificial intelligence technologies for medical imaging.

The patient constituents were welcomed into 16 lawmaker offices from 5 different states, where they discussed the potential for AI imaging technologies and advocated for increased access to these innovations. The advocates described how the lack of Medicare reimbursements for most AI medical imaging technologies prevents patients from benefitting from diagnostic AI. A few advocates even shared that they previously had misinterpreted scans, which may have been prevented if today’s AI technologies had been available to their care teams. Advocates urged their lawmakers to work with Medicare to promote patient access and establish a formalized payment pathway for these revolutionary technologies.

Through personal testimonies and bringing together the unique perspectives of cancer survivors and advocates, RSRT’s fly-in not only enabled legislators to hear real-life stories from their constituents but also helped formulate ongoing collaboration among policymakers and patients.

To help support access to innovative AI medical imaging technologies, click here.

More Articles

A Look Ahead to Our Priorities in 2021

February 9, 2021

Over the last year, America’s healthcare system has been tested like never before. As we continue to grapple…

Read More

Exciting Focused Ultrasound News

November 24, 2020

Earlier this year, Right Scan Right Time hosted patient leaders in Washington, DC to advocate for expanded access…

Read More

Artificial Intelligence in Medical Imaging

November 2, 2020

More than 14 years ago, Erika Brown was diagnosed with late-stage colorectal cancer. The diagnosis made her feel…

Read More

Tell the FDA to Ensure Safe Servicing to Protect Patients

July 24, 2020

The medical imaging equipment we rely on to monitor and identify cancer must be serviced and maintained over…

Read More